Related Experiment Videos
Life-threatening retroperitoneal bleeding due to warfarin-drug interactions
1Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong. tykchan@cuhk.edu.hk
Pharmacoepidemiology and Drug Safety
|March 14, 2009
Summary
Topical methyl salicylate potentiated warfarin anticoagulant effects, leading to severe bleeding after trauma. This interaction highlights the risk of over-anticoagulation and bleeding complications, even with topical medication use.
Area of Science:
- Pharmacology
- Internal Medicine
- Clinical Toxicology
Background:
- Warfarin is a common anticoagulant with a narrow therapeutic index.
- Drug interactions and patient factors can significantly alter warfarin's efficacy and safety.
- Preventable bleeding complications associated with warfarin therapy remain a clinical concern.
Observation:
- A patient on warfarin for pulmonary embolism experienced a retroperitoneal and intramuscular hematoma after a fall.
- The patient had been applying topical methyl salicylate (50% analgesic balm) for three days prior to the event.
- Laboratory tests revealed elevated INR and decreased hemoglobin levels, indicating over-anticoagulation and bleeding.
Findings:
- Concurrent use of topical methyl salicylate significantly potentiated the anticoagulant effect of warfarin.
- Over-anticoagulation, exacerbated by potential platelet dysfunction and minor trauma, led to severe bleeding.
- Prompt management with warfarin cessation, blood products, vitamin K1, and an inferior vena cava filter was initiated.
Implications:
- Clinicians must be aware of potential interactions between topical agents and oral anticoagulants like warfarin.
- Patient education regarding the risks of combining certain topical products with warfarin is crucial.
- Vigilant monitoring of INR and clinical signs of bleeding is essential in patients using warfarin, especially when other medications or topical agents are introduced.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...